These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 38556550)

  • 21. Genome Engineering for Personalized Arthritis Therapeutics.
    Adkar SS; Brunger JM; Willard VP; Wu CL; Gersbach CA; Guilak F
    Trends Mol Med; 2017 Oct; 23(10):917-931. PubMed ID: 28887050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational Tools and Resources for CRISPR/Cas Genome Editing.
    Li C; Chu W; Gill RA; Sang S; Shi Y; Hu X; Yang Y; Zaman QU; Zhang B
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):108-126. PubMed ID: 35341983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9 for Human Genome Engineering and Disease Research.
    Xiong X; Chen M; Lim WA; Zhao D; Qi LS
    Annu Rev Genomics Hum Genet; 2016 Aug; 17():131-54. PubMed ID: 27216776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A detection method for the capture of genomic signatures: From disease diagnosis to genome editing.
    Benamozig O; Baudrier L; Billon P
    Methods Enzymol; 2021; 661():251-282. PubMed ID: 34776215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analyzing the functional effects of DNA variants with gene editing.
    Cooper S; Obolenski S; Waters AJ; Bassett AR; Coelho MA
    Cell Rep Methods; 2024 May; 4(5):100776. PubMed ID: 38744287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering.
    Wada N; Ueta R; Osakabe Y; Osakabe K
    BMC Plant Biol; 2020 May; 20(1):234. PubMed ID: 32450802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Advances in CRISPR-Cas-mediated genome editing system in plants].
    Wang C; Wang K
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1712-1722. PubMed ID: 29082719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas9-Mediated Genome Editing in Paenibacillus polymyxa.
    Ravagnan G; Meliawati M; Schmid J
    Methods Mol Biol; 2024; 2760():267-280. PubMed ID: 38468094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in Engineering the Fly Genome with the CRISPR-Cas System.
    Bier E; Harrison MM; O'Connor-Giles KM; Wildonger J
    Genetics; 2018 Jan; 208(1):1-18. PubMed ID: 29301946
    [No Abstract]   [Full Text] [Related]  

  • 31. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
    Ishino Y; Krupovic M; Forterre P
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic applications of CRISPR/Cas9 gene editing technology for the treatment of ocular diseases.
    Sundaresan Y; Yacoub S; Kodati B; Amankwa CE; Raola A; Zode G
    FEBS J; 2023 Nov; 290(22):5248-5269. PubMed ID: 36877952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Not Only Editing: A Cas-Cade of CRISPR/Cas-Based Tools for Functional Genomics in Plants and Animals.
    Devillars A; Magon G; Pirrello C; Palumbo F; Farinati S; Barcaccia G; Lucchin M; Vannozzi A
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new era in functional genomics screens.
    Przybyla L; Gilbert LA
    Nat Rev Genet; 2022 Feb; 23(2):89-103. PubMed ID: 34545248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly parallel genome variant engineering with CRISPR-Cas9.
    Sadhu MJ; Bloom JS; Day L; Siegel JJ; Kosuri S; Kruglyak L
    Nat Genet; 2018 Apr; 50(4):510-514. PubMed ID: 29632376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Haeussler M; Concordet JP
    J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?
    Carpenter JC; Lignani G
    Neurotherapeutics; 2021 Jul; 18(3):1515-1523. PubMed ID: 34235638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From Descriptive to Functional Genomics of Leukemias Focusing on Genome Engineering Techniques.
    Balla B; Tripon F; Banescu C
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
    Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
    Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.